- Fatigue in Multiple Sclerosis Linked to Regional Brain Damage
Multiple Sclerosis News Today – Fatigue, a common symptom of multiple sclerosis, could be a result of regional damage in the brain.
- Multiple sclerosis Reactivation of Epstein–Barr or herpes viruses not associated with MS relapse
Nature.com – Infection with the Epstein–Barr virus or human herpesvirus 6 is associated with the initial onset of multiple sclerosis (MS)
- SLU researchers see possible answer to chemo pain in a multiple sclerosis drug
Science Codex – A medication called FTY720 (Gilenya) is FDA-approved as a therapy for multiple sclerosis.
- Researchers publish one of the longest longitudinal studies of cognition in multiple sclerosis
Medical Xpress – The article, “Cognitive impairment in multiple sclerosis: An 18-year follow-up study,” was epublished by Multiple Sclerosis and Related Disorders.
- Roche Turns to MS Research on Agreement with Versant Ventures
Multiple Sclerosis News Today – … will be dedicated mostly to the development of therapies for multiple sclerosis. Inception 5′s research will focus on multiple molecular targets.
- Embryonic Stem Cells Will Offer Treatment For Multiple Sclerosis: Study
Counsel & Heal – Researchers have identified a novel approach to treating multiple sclerosis using human embryonic stem cells.
- Parasitic worm in pigs could help relieve symptoms of arthritis, multiple sclerosis, diabetes and …
Herald Sun – … but it does not harm humans, and there is even evidence it can lessen symptoms in people with multiple sclerosis and inflammatory bowel disease.
- Researchers Report Alternate Explanation Discovery Of How And Why CCSVI Treatment Works In …
Multiple Sclerosis News Today – … effects of “chronic cerebro-spinal venous insufficiency” (CCSVI or CCVI) treatment for Multiple Sclerosis (MS) and certain other disease conditions.
- Pregnancy Hormone Drastically Cuts Relapse Rates in Women with MS
Healthline – Women with multiple sclerosis (MS) have long claimed that their disease seems to go into remission when they’re pregnant, and that they feel better.
- Human embryonic stem cells perform well in multiple sclerosis mouse study
BioNews – ‘The cells not only reduced the clinical symptoms of multiple sclerosis but prevented demyelination, which disrupts the ability of the nervous system.
- Compassionate Use Trial of Innate Immunotherapeutics’ Multiple Sclerosis Drug Shows Positive…
Multiple Sclerosis News Today – Australian biotechnology company Innate Immunotherapeutics’ trial for a drug to treat secondary progressive multiple sclerosis (SPMS).
- Trial looks for new ways to treat progressive MS
Globalnews.ca – … but like many patients with Relapsing Remitting MS, Gerke’s disease progressed to a condition known as Secondary Progressive Multiple Sclerosis.
- AUBMC Launches Phase Two of the National Multiple Sclerosis Awareness Campaign in…
Zawya (registration) – said Dr. Samia Khoury, Director of Abu Haidar Neuroscience Institute and Multiple Sclerosis Center at AUBMC and Associate Dean.
Medical treatment news
- Physiotherapist Creates Group Exercise Manual for MS Patients
Multiple Sclerosis News Today – Group exercise could be very beneficial in improving the health of multiple sclerosis patients, according to Sheila Lennon, Physiotherapy Professor.
- Researcher Recommends Brain Imaging To Treat MS-Related Depression
Multiple Sclerosis News Today – Magnetic resonance imaging (MRI) can predict responses to depression treatment in patients with multiple sclerosis (MS).
- Fingolimod (Gilenya) licence extended
MS Trust – … the extension of the licence for fingolimod to allow greater access to the drug for people with highly active relapsing remitting multiple sclerosis.
- Low carb high fat keto diet helps epilepsy, MS, depression, cancer, weight loss
Examiner.com – Despite those preliminary changes, Dr. Wahls continued to decline and received a second diagnosis of secondary progressive multiple sclerosis.
- Overcoming Multiple Sclerosis: George Jelinek
WSIU – George Jelinek was diagnosed with Multiple Sclerosis in 1999 at the age of 45. The Australian Professor of Emergency Medicine has been successful…
- Noted Interventional Radiologist Unveils a Modified Approach to the Treatment of Autonomic…
DigitalJournal.com – This treatment for autonomic dysfunction shows promise for patients who suffer from Multiple Sclerosis.
- Chronic Cerebrospinal Venous Insufficiency Is Not a Cause of Multiple Sclerosis
Multiple Sclerosis News Today – The controversy lies in whether or not CCSVI causes multiple sclerosis, which makes the “liberation procedure” to open veins and improve blood flow.
- Why We Can’t Say What Multiple Sclerosis Looks Like
Care2.com – What vision comes to mind when you hear the words “multiple sclerosis?”
- After The Fall, A Young Man Chronicles His Life With MS
Capital Public Radio News – Jason DaSilva was diagnosed with multiple sclerosis at age 25. He has applied his skills as a documentary filmmaker to show what it’s like.
- Multiple Sclerosis Foundation Launches First MS Online Radio Station
Multiple Sclerosis News Today – MSFocusRadio.org Recently launched by the non-profit Multiple Sclerosis Foundation (MSF), MSFocusRadio.org is the first online radio station.
- Biogen to reapply for HSE funding for multiple sclerosis drug
Irish Times – The makers of a drug that helps people with multiple sclerosis to walk are to make a fresh application to have it covered by the Health Service.
- Jack Osbourne follows strict Paleo Diet to help his fight against Multiple Sclerosis
Irish Independent – Multiple Sclerosis is a chronic disease where the body attacks the myelin sheaths that protects the nerves.
- New Guidelines for Categorizing MS
Everyday Health – In their paper, Defining the Clinical Course of Multiple Sclerosis, the committee reviewed the different phenotypes of multiple sclerosis.
- Better MS Tracking Tool Developed by Robarts Institute Scientists At University of Western Ontario
Multiple Sclerosis News Today – … at the University of Western Ontario’s Robarts Research Institute have developed a better way to track the progression of Multiple Sclerosis.
- Multiple Sclerosis — KOL Insight and Consensus Outlook Modules
DigitalJournal.com – The multiple sclerosis treatment landscape has undergone dramatic changes over the past year.
- British Columbia to Reimburse TECFIDERA(TM), a First-Line Oral Treatment for Multiple Sclerosis
MarketWatch – TECFIDERAT is a first-line oral treatment for adults with relapsing-remitting multiple sclerosis (RRMS).
- Roche and Inception create multiple sclerosis-focused joint venture
Zenopa – Roche and Inception create multiple sclerosis-focused joint venture Roche has announced an exclusive partnership with Inception Sciences.
- Biogen Idec and AbbVie report positive multiple sclerosis drug data
Zenopa – Biogen Idec and AbbVie have announced positive top-line phase III clinical trial data for a new therapy for relapsing-remitting multiple sclerosis
- REFILE-Receptos shares soar as lead drug meets main goal
Reuters – Multiple sclerosis is an incurable and unpredictable disease of the central nervous system, whose cause is still largely undetermined.
© Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2014. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.